[Indications and uncertainties of antiaggregating agents].
D000925:Anticoagulants / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D002994:Clofibrate / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D010974:Platelet Aggregation / Q000187:drug effects*; D013442:Sulfinpyrazone / Q000494:pharmacology; D013923:Thromboembolism / Q000517:prevention & control; D013924:Thrombophlebitis / Q000517:prevention & control
D000925:Anticoagulants; D004176:Dipyridamole; D002994:Clofibrate; D001241:Aspirin; D013442:Sulfinpyrazone
Indications et incertitudes des agents antiagrégants.